Top

Published in:

01-01-2014 | Nephrology - Case report

Medical therapy alone can be sufficient for bilateral emphysematous pyelonephritis: report of a new case and review of previous experiences

Authors: Mohammad Shafi Kuchay, Bashir Ahmad Laway, Manzoor Ahmad Bhat, Shahnaz Ahmad Mir

Published in: International Urology and Nephrology | Issue 1/2014

Abstract

Bilateral emphysematous pyelonephritis (EPN) is an extremely uncommon, life-threatening gas-forming infection of renal parenchyma and its surrounding areas. Surgical treatment, including percutaneous catheter drainage and nephrectomy, has been advocated as the treatment of choice in most of the patients. However, nephrectomy is itself a hazardous intervention in an unstable septic patient. Whenever bilateral disease is present, the need for long-term renal replacement therapy is unavoidable. We present the clinical course of a lady who presented with bilateral EPN and was successfully managed by medical therapy alone. We also reviewed almost all published cases of bilateral EPN that had been managed medically.

Asgari SA (2004) Successful medical treatment of emphysematous pyelonephritis. Urol J 1:282–283PubMed

Huang JJ, Tseng CC (2000) Emphysematous pyelonephritis clinicoradiological classification, management, prognosis and pathogenesis. Arch Intern Med 160:797–805PubMedCrossRef

Shigemura K, Yasufuku T, Yamashita M, Arakawa S, Fujisawa M (2009) Bilateral emphysematous pyelonephritis cured by antibiotics alone: a case and literature review. Jpn J Infect Dis 62:206–208PubMed

Naggapan R, Kletchko S (1992) Bilateral emphysematous pyelonephritis resolving to medical therapy. J Intern Med 232:77–80CrossRef

George J, Chakravarthy S, John GT, Jacob CK (1995) Bilateral emphysematous pyelonephritis responding to nonsurgical management. Am J Nephrol 15:172–174PubMedCrossRef

Angulo JC, Dehaini A, Escribano J et al (1997) Successful conservative management of emphysematous pyelonephritis, bilateral or in a solitary kidney. Scand J Urol Nephrol 31:193–197PubMedCrossRef

Shimizu H, Hariu K, Kamiyama Y et al (1999) Bilateral emphysematous pyelonephritis with autosomal-dominant polycystic kidney disease successfully treated by conservative method. Urol Int 63:252–254PubMedCrossRef

Arun N, Hussain A, Kapoor MM, Abul F (2007) Bilateral emphysematous pyelonephritis and emphysematous cystitis with autosomal-dominant polycystic kidney disease: is conservative management justified? Med Prince Pract 16:155–157CrossRef

Grozel F, Berthezene Y, Guerin C et al (1997) Bilateral emphysematous pyelonephritis resolving to medical therapy: demonstration by US and CT. Eur Radiol 7:844–846PubMedCrossRef

10.

Hildebrand TS, Nibbe L, Frei U, Schindler R (1999) Bilateral emphysematous pyelonephritis caused by Candida infection. Am J Kidney Dis 33:E10PubMedCrossRef

11.

Tahir H, Thomas G, Sheerin N, Bettington H, Pattison JM, Goldsmith DJ (2000) Successful medical treatment of acute bilateral emphysematous pyelonephritis. Am J Kidney Dis 36:1267–1270PubMedCrossRef

12.

Flores G, Nellen H, Magaña F, Calleja J (2002) Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: a case report and review of the literature. BMC Nephrol 3:4PubMedCentralPubMedCrossRef

13.

Sodgi M, Marih L, Nassib M, Himmich H (2006) Bilateral emphysematous pyelonephritis cured by medical therapy alone. Med Mal Infect 36:174–176CrossRef

14.

Karasavidou L, Nikolaou S, Archontakis S, Papatheodorou G et al (2006) Nonsurgical treatment of bilateral emphysematous pyelonephritis in a diabetic patient. J Nephrol 19:664–667PubMed

15.

Melero MJ, Sarquis SG, Biancolini C, Baredes N (2007) Acute bilateral emphysematous pyelonephritis: a therapeutic challenge. Medicina (B Aires) 67:282–284

Title: Medical therapy alone can be sufficient for bilateral emphysematous pyelonephritis: report of a new case and review of previous experiences
Authors: Mohammad Shafi Kuchay
Bashir Ahmad Laway
Manzoor Ahmad Bhat
Shahnaz Ahmad Mir
Publication date: 01-01-2014
Publisher: Springer Netherlands
Published in: International Urology and Nephrology / Issue 1/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-013-0446-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin

Churg–Strauss syndrome presenting with acute kidney injury in a case of primary focal segmental glomerulosclerosis

Peritoneal dialysis outcomes in a modern cohort of overweight patients

High-density lipoprotein in uremic patients: metabolism, impairment, and therapy

Effect of dietary sodium restriction on body water, blood pressure, and inflammation in hemodialysis patients: a prospective randomized controlled study

Local ethanol injection for the treatment of deltoid parathyroid cell hyperplasia

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials